Fidelity Investments’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,537
Closed -$61.9K 5507
2025
Q1
$61.9K Sell
12,537
-146,665
-92% -$466K ﹤0.01% 3763
2024
Q4
$468K Buy
159,202
+10,657
+7% +$43.7K ﹤0.01% 2959
2024
Q3
$701K Buy
148,545
+26,738
+22% +$121K ﹤0.01% 2729
2024
Q2
$469K Buy
121,807
+34,116
+39% +$154K ﹤0.01% 2753
2024
Q1
$469K Buy
87,691
+330
+0.4% +$1.55K ﹤0.01% 2741
2023
Q4
$373K Sell
87,361
-200,176
-70% -$615K ﹤0.01% 2768
2023
Q3
$1.13M Sell
287,537
-30,373
-10% -$199K ﹤0.01% 2426
2023
Q2
$3.22M Buy
317,910
+11,673
+4% +$124K ﹤0.01% 2188
2023
Q1
$3.12M Sell
306,237
-286,635
-48% -$3.28M ﹤0.01% 2243
2022
Q4
$5.56M Buy
592,872
+232,066
+64% +$3.27M ﹤0.01% 2083
2022
Q3
$5.25M Buy
360,806
+567
+0.2% +$8.42K ﹤0.01% 2158
2022
Q2
$4.75M Buy
360,239
+360,051
+191,516% +$4.91M ﹤0.01% 2251
2022
Q1
$3K Buy
188
+185
+6,167% +$3.14K ﹤0.01% 4593
2021
Q4
$0 Buy
+3
New +$94 ﹤0.01% 4930

Other funds holding TSVT

Fidelity Investments's TSVT Position: Q2 2025 in Review

Fidelity Investments sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 12,537 shares — an estimated $61.9K sold.

Fidelity Investments first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $5.56M in Q4 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Fidelity Investments reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Fidelity Investments sold 12,537 2seventy bio shares in Q2 2025, an estimated $61.9K.
  • Fidelity Investments first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Fidelity Investments's 2seventy bio position peaked at $5.56M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.